Citi Reiterates Neutral Rating on Integra LifeSciences (IART)

July 15, 2024 9:23 AM UTC Send to a Friend
Citi analyst Joanne Wuensch reiterated a Neutral rating and $30.00 price target on Integra LifeSciences (NASDAQ: IART).The analyst comments "After ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login